Acasti Pharma Debt/Equity Ratio 2014-2024 | GRCE

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Current Ratio Quick Ratio Debt/Equity Ratio ROE ROA ROI Return Tangible Eq

Acasti Pharma debt/equity ratio from 2014 to 2024. Debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity.

Acasti Pharma Debt/Equity Ratio 2014-2024 | GRCE

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Current Ratio Quick Ratio Debt/Equity Ratio ROE ROA ROI Return Tangible Eq

Acasti Pharma debt/equity ratio from 2014 to 2024. Debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity.

Related Stocks
Company Name	Market Cap
Merck (MKKGY)	$21.3B
New York Community Bancorp (FLG)	$4.3B